BEDFORD, MA, (June 29, 2005) -- Hologic, Inc., a leading provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women's health, today announced it has entered into a definitive agreement to acquire the intellectual property of Fischer Imaging Corporation relating to its mammography business and products, including the rights to their SenoScan digital mammography and MammoTest stereotactic breast biopsy systems. Fischer Imaging located in Denver, Colorado designs, manufactures and markets medical imaging systems for the screening and diagnosis of breast cancer.

Under the terms of the agreement, Hologic has agreed to acquire Fischer's mammography intellectual property for a cash purchase price of $32 million. Additionally, Hologic agreed to extend a $5 million secured loan to Fischer as of the execution of the agreement, which amount will be credited toward the $32 million purchase price if the transaction is completed, but which will otherwise be due and payable by Fischer to Hologic. The acquisition is expected to close in 90-120 days and is subject to customary closing conditions and the approval of Fischer's shareholders.

"Expanding our market share in women's health is a key element in the growth of our company," said Jack Cumming, Chairman and Chief Executive Officer. "The acquisition of these technologies is consistent with the company's strategy of looking to the future and building upon our established technology roadmap. Through a planned approach of ongoing technological advances and acquiring some of the best intellectual property in the field, Hologic has been able to offer innovative solutions to our customers. We believe this acquisition provides us additional technical capabilities and customer relationships to further solidify our position of strength in the growing mammography market."

More Industry Headlines